4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001193125-26-203374
Chief Operating Officer acquired 11,770 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hensley Mark Earl · Chief Operating Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-30 | Exercise or conversion : show line 1 in the form | +11,770 | 11,770 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-30 | Exercise or conversion : show line 2 in the form Restricted Stock Units | −11,770 | 176,545 | D |
Loading xslF345X06/ownership.xml…